[1] Metzger BE. The organizing committee: summary and recomendations of the third International Workshop-Conference on Gestacional Diabetes Mellitus[J]. Diabetes, 1991, 40(suppl 2):197-201. [2] 杨红. 惊恐障碍患者发病原因与病理机制的探讨[J]. 中华现代临床医学杂志, 2005, 3(5):411-413. [3] 李玮. 惊恐障碍的病因和发病机理研究[J]. 国外医学精神病学分册, 1990, 17(4):202-203. [4] 王振, 肖泽萍, 陈珏, 等. 焦虑症的生化病理机制探讨[J]. 临床精神医学杂志, 2003, 13(1):1-3. [5] Stork Oji FY, Kaneko K. Postnatal development of a GABA deficit and disturbance of neural functions in mice lacking GAD65[J]. Brain, 2000, 865(1):45-58. [6] Goddard AW, Mason GF, Appel M, et al. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder[J]. Am J Psychiatry, 2004, l6l(12):2l86-2193. [7] Roestel C, Hoeping W, Deckert J. Hypophosphatemia in panic disorder[J]. Am J Psychiatry, 2004, l6l(8):1499-1500. [8] Clark CR, McFarlane AC, Weber DL, et al. Enlarged frontal P300 to stimulus changes in Panic disorder[J]. Biological Psychiatry, 1996, 39(10):845-856. [9] Wang J, Miyazato H, Randall M, et al. The N200 abnormalities of auditory event-related potentials in patients with panic disorder. [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27(6):1013-1021. [10] RaskinM, Peeke HV, Dickman W, et al. Panic and generalized anxiety disorders. Developmental antecedents and precipitants[J]. Arclt Gen Psy chiatry, 1982, 39(6):687 -689. [11] Milrod B, Leon AC, Shear MK. Can interpersonal loss precipitate panic disorder[J] ? Am J Psychiatry, 2004, 161(4):758-759. [12] Bandelow B, Spath C, Tichauer GA, et al. Early traumatic life events, parental attitudes, family history and birth risk factors in patients with panic disorder[J]. Compr Psychiatry, 2002, 43(4):269-278. [13] 卢乐萍, 刘雪虹, 王力娥. 惊恐障碍患者的心理健康水平及个性特征[J]. 中国临床康复, 2004, 8(3):410-411. [14] 刘秀芬, 黄悦勤, 李立明. 人格障碍及其与父母教养方式关系的研究[J]. 中国心理卫生杂志, 2000, 14(2):96-98. [15] 岳冬梅. 父母教养方式:EMBU 的初步修订及其在神经症患者的应用[J]. 中国心理卫生杂志, 1993, 7(3):97-101. [16] 陈勇明. 惊恐障碍治疗的新进展[J]. 国外医学精神病学分册, 1994, 21(2):94-96. [17] 伊茂森, 李文红. 惊恐障碍的药物治疗[J]. 滨州医学院学报, 2000, 23(2):203-204. [18] 付崇铭, 唐济生. 惊恐障碍药物治疗的副作用和治疗依从性[J]. 中国行为医学科学, 1999, 8(3):237-238. [19] 张琳. 惊恐障碍的药物治疗[J]. 国外医学精神病学分册, 2000, 27(3):166-170. [20] 杨海晨, 胡纪泽. 惊恐障碍的维持治疗[J]. 临床精神医学杂志, 2003, 13(1):50-51. [21] 李, 郑涌. 惊恐障碍的综合治疗特点[J]. 中国临床康复, 2006, 10(22):147-150. [22] Mitte K. Psychotherapy plus antidepressant therapy increases response rate in people with panic disorder more than either treatment alone[J]. Evid Based Ment Health,2006, 9(4):98. [23] 赵长银, 王永萍, 沈学武, 等. 博乐欣合并认知行为治疗惊恐障碍对照研究[J]. 山东精神医学, 2003, 16(1):11-12. [24] 崔维珍, 王东明, 于国勤. 帕罗西汀合并认知行为疗法治疗惊恐障碍疗效分析[J]. 山东精神医学, 2004,17(4):236-237. [25] 刘宏, 崔维珍, 王立钢, 等. 帕罗西汀并认知行为疗法治疗惊恐障碍临床对照研究[J]. 齐鲁医学杂志,2005, 20(6):489-492. [26] 党雷, 索爱芹, 刘超. 舍曲林合并认知行为疗法治疗惊恐障碍14 例[J]. 中国心理卫生杂志, 2002, 16(5):356-357. [27] Schmidt NB, Smith JD. Do medications matter in the context of cognitive behavior therapy for panic disorder[J]. Cognit Psychol, 2005, l9(4):347. |